ORDER
REPRINTS
78
Liang and Grindley
colorless solid, yield 99 mg (92%); m.p. 177–1788C; [a]D 2 8.38 (c 0.3, CHCl3); 1H NMR
d: 8.07 (d, 2H, J ¼ 7.5 Hz, o-Ph), 7.59 (t, 1H, J ¼ 7.5 Hz, p-Ph), 7.45 (t, 2H, J ¼ 7.5 Hz,
m-Ph), 5.79 (d, 1H, JNH,2 ¼ 9.3 Hz, NH), 5.46 (dd, 1H, J2,3 ¼ 10.8 Hz, J3,4 ¼ 3.4 Hz,
H-3), 4.78 (dt, 1H, J1,2 ¼ 3.7 Hz, H-2), 4.71 (d, 1H, H-1), 4.11 (m, 1H, H-5), 3.93 (dd,
1H, J3,4 ¼ 3.4 Hz, J4,5 ¼ 2.1 Hz, H-4), 3.38 (s, 3H, OCH3), 1.87 (s, 3H, COCH3), 1.33
(d, 3H, J5,6 ¼ 7.6 Hz, CH3-6); 13C NMR d: 169.9, 166.6 (2 ꢀ C55O), 133.6, 128.61,
128.57 (Ph), 98.8 (C-1), 71.9 (C-3), 64.8 (C-4), 64.2 (C-5), 55.3 (OCH3), 47.7 (C-2),
23.3 (COCH3), 17.3 (C-6).
Anal. Calcd for C16H20N4O5 (348.3616): C, 55.17; H, 5.79; N, 16.08. Found: C,
55.26; H, 5.71; N, 15.74.
Methyl 2,4-diacetamido-2,4,6-trideoxy-a-D-galactopyranoside (9). Compound 7
(49.9 mg, 0.13 mmol) in dry methanol (5 mL) containing 10% Pd/C (74.8 mg, 50%
wet) was stirred under hydrogen at atmospheric pressure. After the disappearance of 7
(19 hr) on TLC (ethyl acetate : hexane, 3 : 1), the catalyst was removed by filtration. Con-
centration yielded a colorless solid, that was taken up in pyridine (2 mL) and acetic anhy-
dride (2.0 mL, 0.2 mmol, 4 equiv.). The reaction mixture was stirred at r.t. until the amino
compound had disappeared on TLC (chloroform : methanol, 8 : 1) (0.5 hr). The reaction
mixture was quenched with methanol (5 mL), and evaporated to give the diacetamide as
a syrup. This syrup was dissolved in methanol (4 mL) and sodium methoxide was
added (0.8 mL, 30 mg sodium in 6 mL methanol). After being stirred at r.t. for 1 hr, the
reaction mixture was neutralized with Amberlite IR-120(Hþ), filtered, and concentrated
to a yellow syrup. The syrup was separated on a column of silica gel (ethyl acetate : metha-
nol, 6 : 1) into two components. The first component, compound 9 was a colorless solid,
1
yield 33.8 mg (74%); m.p. 213–2158C; [a]D þ 125.98 (c 0.5, ethanol); H NMR d: 6.10
(d, 1H, JNH,4 ¼ 7.8 Hz, NH-4), 5.82 (d, 1H, JNH,2 ¼ 9.4 Hz, NH-2), 4.69 (d, 1H,
J1,2 ¼ 4.1 Hz, H-1), 4.31 (m, 1H, H-4), 4.13–4.07 (m, 2H, H-2, H-5), 3.92 (dd, 1H,
J2,3 ¼ 10.8 Hz, J3,4 ¼ 4.0 Hz, H-3), 3.35 (s, 3H, OCH3), 2.12, 2.04 (2s, 2 ꢀ 3H,
2 ꢀ COCH3), 1.17 (d, 3H, J5,6 ¼ 6.6 Hz, CH3-6); 13C NMR (D2O) d: 178.4, 177.3
(2 ꢀ C55O), 101.0 (C-1), 69.7 (C-3), 68.0 (C-5), 58.0 (OCH3), 56.2 (C-4), 52.9 (C-2),
24.7 (2 ꢀ COCH3), 18.3 (C-6).
HRMS (EI, m/z) Calcd for [C11H20N2O5 2 CH3OH]þ: 228.1110. Found: 228.1110.
The second component, methyl 2-acetamido-4-benzamido-2,4,6-trideoxy-a-D-galac-
topyranoside (9a) was isolated as a colorless syrup, yield: 9 mg (21%); [a]D þ 140.58 (c
0.9, ethanol); 1H NMR d: 7.85–7.42 (m, 5H, Ph), 6.69 (d, JNH,4 ¼ 7.4 Hz, NH-4), 6.01 (bs,
1H, NH-2), 4.75 (d, 1H, J1,2 ¼ 3.7 Hz, H-1), 4.51 (m, 1H, H-4), 4.16–3.98 (m, 3H, H-2,
H-3, H-5), 3.36 (s, 3H, OCH3), 1.96 (s, 3H, COCH3), 1.22 (d, 3H, J5,6 ¼ 5.5 Hz, CH3-6);
13C NMR d: 171.4, 169.9 (2 ꢀ C55O), 133.9, 131.9, 128.6, 127.3 (Ph), 98.5 (C-1), 69.4(C-
3), 64.8 (C-5), 55.5 (OCH3), 54.4 (C-4), 51.0 (C-2), 23.3 (COCH3), 16.9 (C-6).
Methyl 2-acetamido-4-azido-2,4,6-trideoxy-a-D-galactopyranoside (2). Sodium
(0.02 g, 0.80 mmol) was dissolved in dry methanol (6 mL) and compound 7 (0.25 g,
0.71 mmol) was added. After 5 min, the solution was neutralized with Amberlite IR-120
(Hþ), filtered, washed with methanol (2 ꢀ 5 mL) and evaporated to a colorless solid.
Recrystallization from ethyl acetate–hexane gave colorless needles, yield: 0.15 g
1
(98%); m.p. 195.5–197.08C; [a]D þ 152.48 (c 0.6, ethanol); H NMR d: 5.92 (d, 1H,
JNH,2 ¼ 9.5 Hz, NH), 5.09 (dd, 1H, J2,3 ¼ 10.4 Hz, J3,4 ¼ 9.5 Hz, H-3), 4.64 (d, 1H,
J1,2 ¼ 4.1 Hz, H-1), 4.28 (ddd, 1H, H-2), 3.64 (s, 1H, OH-4), 3.56 (m, 1H, H-5), 3.32
(dd, J4,5 ¼ 10.3 Hz, H-4), 3.21 (s, 3H, OCH3), 1.61 (s, 3H, COCH3), 1.12 (d, 3H,